• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
BlackDoctor.org
Where Wellness & Culture Connect

Where Wellness & Culture Connect

  • Health Conditions
  • Wellness
  • Lifestyle
  • Longevity
  • Resource Centers
    • Cancer Resource Center
    • Covid Resource Center
    • Clinical Trials Resource Center
  • Find A Doctor
  • BDO TV
Home / Health Conditions / Leukemia: Acute Myeloid / New FDA-Approved Therapy Is A Breakthrough For Blood Cancer Patients 

New FDA-Approved Therapy Is A Breakthrough For Blood Cancer Patients 

Leukemia awarenessThe U.S. Food and Drug Administration today [April 28, 2017] approved Rydapt (midostaurin) for the treatment of adult patients with newly diagnosed acute myeloid leukemia (AML) who have a specific genetic mutation called FLT3, in combination with chemotherapy. The drug is approved for use with a companion diagnostic, the LeukoStrat CDx FLT3 Mutation Assay, which is used to detect the FLT3 mutation in patients with AML.

AML is a rapidly progressing cancer that forms in the bone marrow and results in an increased number of white blood cells in the bloodstream. The National Cancer Institute estimated that approximately 19,930 people would be diagnosed with AML in 2016 and 10,430 were projected to die of the disease.

“Rydapt is the first targeted therapy to treat patients with AML, in combination with chemotherapy,” said Richard Pazdur, M.D., acting director of the Office of Hematology and Oncology Products in the FDA’s Center for Drug Evaluation and Research and director of the FDA’s Oncology Center of Excellence. “The ability to detect the gene mutation with a diagnostic test means doctors can identify specific patients who may benefit from this treatment.”

Rydapt is a kinase inhibitor that works by blocking several enzymes that promote cell growth. If the FLT3 mutation is detected in blood or bone marrow samples using the LeukoStrat CDx FLT3 Mutation Assay, the patient may be eligible for treatment with Rydapt in combination with chemotherapy.

You May Also Like
13 Signs You Need to See a Dermatologist

The safety and efficacy of Rydapt for patients with AML were studied in a randomized trial of 717 patients who had not been treated previously for AML. In the trial, patients who received Rydapt in combination with chemotherapy lived longer than patients who received chemotherapy alone, although a specific median survival rate could not be reliably estimated. In addition, patients who received Rydapt in combination with chemotherapy in the trial went longer (median 8.2 months) without certain complications (failure to achieve complete remission within 60 days of starting treatment, progression of leukemia or death) than patients who received chemotherapy alone (median three months).

Common side effects of Rydapt in patients with AML include low levels of white blood cells with fever (febrile neutropenia), nausea, inflammation of the mucous membranes (mucositis), vomiting, headache, spots on the skin due to bleeding (petechiae), musculoskeletal pain, nosebleeds (epistaxis), device-related infection, high blood sugar (hyperglycemia) and upper respiratory tract infection. Rydapt should not be used in patients with hypersensitivity to midostaurin or other ingredients in Rydapt. Women who are pregnant or breastfeeding should not take Rydapt because it may cause harm to a developing fetus or a newborn baby. Patients who experience signs or symptoms of lung damage (pulmonary toxicity) should stop using Rydapt.

Rydapt was also approved today for adults with certain types of rare blood disorders (aggressive systemic mastocytosis, systemic mastocytosis with associated hematological neoplasm or mast cell leukemia). Common side effects of Rydapt in these patients include nausea, vomiting, diarrhea, swelling (edema), musculoskeletal pain, abdominal pain, fatigue, upper respiratory tract infection, constipation, fever, headache and shortness of breath.

The FDA granted this application Priority Review, Fast Track (for the mastocytosis indication) and Breakthrough Therapy (for the AML indication) designations.

You May Also Like
7 Proven Ways to Cure an Upset Stomach

The FDA granted the approval of Rydapt to Novartis Pharmaceuticals Corporation. The FDA granted the approval of the LeukoStrat CDx FLT3 Mutation Assay to Invivoscribe Technologies Inc.

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

May 1, 2017 by Team BlackDoctor.org

Read Next Article

The Latest In Leukemia: Acute Myeloid

Rookie Football Star Missing NFL Season Due to Leukemia Diagnosis

Some young men spend most of their childhood dreaming of playing in the NFL. Houston Texans wide receiver John Metchie III had similar dreams, but had those dreams sidelined due to an unseen illness. Metchie has been diagnosed with acute read more about Rookie Football Star Missing NFL Season Due to Leukemia Diagnosis

Are You Listening To Your Doctor About Your Leukemia?

For anyone, finding out that they have any type of illness, let alone cancer, can be a life-altering event. From the time of diagnosis, it can be challenging to juggle your life, mindset, finances, and the disease. According to a read more about Are You Listening To Your Doctor About Your Leukemia?
African American man and doctor nurse caregiver

What Happens After AML Treatment

Completing treatment for acute myeloid leukemia (AML) can feel like a rollercoaster experience. For some people, treatment may have destroyed the leukemia cells and you may feel excited and relieved to have finished treatment, but at the same time, you read more about What Happens After AML Treatment
hand holding blood test

Simple Blood Test May Detect Return Of Acute Myeloid Leukemia

British researchers say a simple blood test may be a cheap, easy and effective way to spot risk of recurrence of a common form of acute myeloid leukemia (AML). This type of AML is characterized by a mutation in the read more about Simple Blood Test May Detect Return Of Acute Myeloid Leukemia
cute african young woman using instant message

4 Shocking Health Facts You’d Never Guess Were True

For something so crucial to your quality of life as your health, there are certain shocking health facts that can make it difficult to know just what to do to stay healthy. Such as... 1. Night nap or stay awake? read more about 4 Shocking Health Facts You’d Never Guess Were True

Quit to Live: How and Why to Quit Smoking Today

Make this year the year you or someone close to you quits smoking. The following information may be helpful to your efforts. If you’re looking to quit, we encourage you to contact 1–800–QUIT–NOW or www.smokefree.gov for additional support. Quitting Information read more about Quit to Live: How and Why to Quit Smoking Today

Primary Sidebar

Subscribe to our newsletter

Poll

Popular Posts

  • 10 Signs You’re Living With Clogged Arteries 10 Signs You’re Living With Clogged Arteries
  • Tracee Ellis Ross at 50: Loving Her Body With No FilterTracee Ellis Ross at 50: Loving Her Body With No Filter
  • Like Father, Like Son: ‘Miami Vice’ Star’s Son Handsome Like his DaddyLike Father, Like Son: 'Miami Vice' Star's Son Handsome Like his Daddy
  • Mo’Nique at 55: Slimmer, Happier & Wiser: “I Love Us For Real”Mo'Nique at 55: Slimmer, Happier & Wiser: "I Love Us For Real"
  • The Cast of The Bernie Mac Show: 20+ Years LaterThe Cast of The Bernie Mac Show: 20+ Years Later

Footer

Where Wellness & Culture Connect

BDO is the world’s largest and most comprehensive online health resource specifically targeted to African Americans. BDO understands that the uniqueness of Black culture - our heritage and our traditions - plays a role in our health. BDO gives you access to innovative new approaches to the health information you need in everyday language so you can break through the disparities, gain control and live your life to its fullest.

Connect With Us

Learn More About

  • Hepatitis C
  • Diabetes
  • Sickle Cell
  • Mental Health
  • About Us
  • Privacy Policy
  • Advertise With Us
  • BlackDoctor.org Advertising and Sponsorship Policy
  • Daily Vitamina
  • TBH

Copyright © 2023, BlackDoctor, Inc. All rights reserved.